393 related articles for article (PubMed ID: 17092750)
1. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
2. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.
Liu LX; Janvier K; Berteaux-Lecellier V; Cartier N; Benarous R; Aubourg P
J Biol Chem; 1999 Nov; 274(46):32738-43. PubMed ID: 10551832
[TBL] [Abstract][Full Text] [Related]
3. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ
FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502
[TBL] [Abstract][Full Text] [Related]
4. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
[TBL] [Abstract][Full Text] [Related]
5. Human adrenoleukodystrophy protein and related peroxisomal ABC transporters interact with the peroxisomal assembly protein PEX19p.
Gloeckner CJ; Mayerhofer PU; Landgraf P; Muntau AC; Holzinger A; Gerber JK; Kammerer S; Adamski J; Roscher AA
Biochem Biophys Res Commun; 2000 Apr; 271(1):144-50. PubMed ID: 10777694
[TBL] [Abstract][Full Text] [Related]
6. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
8. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
Baarine M; Beeson C; Singh A; Singh I
J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
[TBL] [Abstract][Full Text] [Related]
9. Biochemical aspects of X-linked adrenoleukodystrophy.
Kemp S; Wanders R
Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
[TBL] [Abstract][Full Text] [Related]
10. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
13. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.
Kemp S; Wei HM; Lu JF; Braiterman LT; McGuinness MC; Moser AB; Watkins PA; Smith KD
Nat Med; 1998 Nov; 4(11):1261-8. PubMed ID: 9809549
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the carboxyl-terminal region of the yeast peroxisomal half ABC transporter Pxa2p in its interaction with Pxa1p and in transporter function.
Chuang CY; Chen LY; Fu RH; Chen SM; Ho MH; Huang JM; Hsu CC; Wang CC; Chen MS; Tsai RT
PLoS One; 2014; 9(8):e104892. PubMed ID: 25118695
[TBL] [Abstract][Full Text] [Related]
15. Live cell FRET microscopy: homo- and heterodimerization of two human peroxisomal ABC transporters, the adrenoleukodystrophy protein (ALDP, ABCD1) and PMP70 (ABCD3).
Hillebrand M; Verrier SE; Ohlenbusch A; Schäfer A; Söling HD; Wouters FS; Gärtner J
J Biol Chem; 2007 Sep; 282(37):26997-27005. PubMed ID: 17609205
[TBL] [Abstract][Full Text] [Related]
16. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
17. Full length cDNA cloning, promoter sequence, and genomic organization of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy.
Holzinger A; Mayerhofer P; Berger J; Lichtner P; Kammerer S; Roscher AA
Biochem Biophys Res Commun; 1999 May; 258(2):436-42. PubMed ID: 10329405
[TBL] [Abstract][Full Text] [Related]
18. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
Kemp S; Berger J; Aubourg P
Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
[TBL] [Abstract][Full Text] [Related]
19. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
[TBL] [Abstract][Full Text] [Related]
20. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]